Opinions of Healthcare Providers About a European Neuromodulation Register

Survey Clinical Trial

Official title:

Opinions of Healthcare Providers About a European Neuromodulation Register: an Online Survey

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06030973
• Other study ID #: PROLOGUE
• Status: Recruiting
• Start date: August 31, 2023
• Est. completion date: September 2, 2023

Study information

• Verified date: September 2023
• Source: Universitair Ziekenhuis Brussel
• Contact: Maarten Moens
• Phone: +3224775514
• Email: stimulusresearchgroup[@]gmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this online survey is to gain further insights in the needs and burden for a European registry for neuromodulation, according to healthcare providers.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: September 2, 2023
• Est. primary completion date: September 2, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Male and female adults who are involved in the management of chronic pain and more specifically in neuromodulation for pain (including but not limited to anesthesiologists, neurosurgeons, nurses).

Exclusion Criteria:

• Not involved in management of chronic pain through neuromodulation.

Related Conditions & MeSH terms

• Neuromodulation
• Registry
• Survey

Intervention

Behavioral:
• Filling in an online survey
Professionals are asked to complete questions regarding 1) the degree of current participation in a registry, 2) the need for a European registry, 3) the items that should be collected and 4) access to the European registry.

Locations

Country	Name	City	State
Germany	Congres Center	Hamburg

Sponsors (2)

Lead Sponsor	Collaborator
Moens Maarten	Vrije Universiteit Brussel

Country where clinical trial is conducted

Germany, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Healthcare providers their current degree of participation in a registry for neuromodulation.	Degree of participation in a registry for neuromodulation (question).	Cross-sectional evaluation during 3th Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg in August-September 2023.
Primary	Healthcare providers their need for a European registry.	Underlying reasons on why a European registry is needed, or not needed (question).	Cross-sectional evaluation during 3th Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg in August-September 2023.
Primary	Items that should be included in a registry for neuromodulation, according to healthcare providers.	Items that should be collection within a registry, evaluated with a multiple choice question.	Cross-sectional evaluation during 3th Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg in August-September 2023.
Primary	Access regulations to European registry for neuromodulation, according to healthcare providers.	Access regulations, evaluated with a multiple choice question.	Cross-sectional evaluation during 3th Joint Congress of the INS European Chapters (e-INS 2023) in Hamburg in August-September 2023.